Long‐term cardiovascular risk in women with hypertensive disorders of pregnancy: Insights from polygenic risk scores
Acta Obstetricia et Gynecologica Scandinavica · 2025
DOI: 10.1111/aogs.70021 ↗Kurz gefasst
Fachartikel in der Zeitschrift Acta Obstetricia et Gynecologica Scandinavica, 2025. Verfasst von Anna Kivioja und 8 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine and Health Technology, Center for Child, Adolescent, and Maternal Health Research, Tampere University, Tampere, Finland. Hauptthemen laut MEDLINE: Hypertension, Pregnancy-Induced, Cardiovascular Diseases. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Finska Läkaresällskapet, Sydäntutkimussäätiö, Suomen Kulttuurirahasto.
Abstract (Originalsprache)
Introduction
The association between preeclampsia (PE) and an elevated risk of cardiovascular disease (CVD) is well documented. Recent genome‐wide association studies of PE have further highlighted their possible common genetic background. We investigated how the history of hypertensive disorders of pregnancy (HDP), including the PE phenotype, and normotensive pregnancy, combined with polygenic risk scores (PRSs) for PE (PE‐PRS), high systolic blood pressure (SBP‐PRS), coronary artery disease (CAD‐PRS) or stroke (stroke‐PRS), affects the risk for CVD. Material and Methods The study was conducted in the FinnGen cohort of 213 942 Finnish women, including 8858 women with PE, 17916 women with any HDP, and 196 026 parous controls. PE women were included in the HDP phenotype. Participants were classified based on their PRSs into three groups: low (80%) genetic risk. Women with normotensive pregnancies and moderate PRSs served as controls.
Results
Women with PE and a high genetic risk for PE, high SBP, CAD, and stroke had a significantly increased risk of CVD compared to women with normotensive pregnancies and a moderate genetic risk. The hazard ratios (HRs) for CVD were 1.87 for PE‐PRS, 2.31 for SBP‐PRS, 1.94 for CAD‐PRS, and 2.07 for stroke‐PRS, all p ‐values 2 × 10 −16 . A similar pattern was observed in women with any HDP. Among women with normotensive pregnancies, a high genetic risk led to only a modest increase in CVD risk. The corresponding HRs were 1.07 for PE‐PRS ( p = 5 × 10 −5 ), 1.32 for SBP‐PRS, 1.19 for CAD‐PRS, and 1.16 for stroke‐PRS (all p values 2 × 10 −16 ). Across all four PRSs, the impact of PE and any HDP on CVD risk was greater than that of genetic risk alone. The elevated CVD risk persisted up to the age of 80.
Conclusions
In women with PE or any HDP, a high genetic risk for PE, high SBP, CAD, and stroke further increases the overall risk of CVD. Among women with normotensive pregnancies, a high genetic risk confers only a modest increase in CVD risk. In evaluating long‐term CVD risk, clinical risk assessment, including obstetric history, appears to outperform genetic risk evaluation using PRSs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Faculty of Medicine and Health Technology, Center for Child, Adolescent, and Maternal Health Research, Tampere University, Tampere, Finland.
- Department of Obstetrics and Gynecology, Kanta-Häme Central Hospital, the Wellbeing Services County of Kanta-Häme, Finland.
- Systems Epidemiology, Research Unit of Population Health, Faculty of Medicine, University of Oulu and Biocenter Oulu, Oulu, Finland.
- Department of Obstetrics and Gynecology, Tampere University Hospital, the Wellbeing Services County of Pirkanmaa, Finland.
- Faculty of Social Sciences, Tampere University, Tampere, Finland.
- Department of Food and Nutrition, University of Helsinki, Helsinki, Finland.
ORCID-Profile: Anna Kivioja, Heini Huhtala, Tiina Jääskeläinen, Hannele Laivuori
Förderung
- Finska Läkaresällskapet
- Sydäntutkimussäätiö
- Suomen Kulttuurirahasto
- Academy of Finland
- Research Council of Finland
Zitieren
APA
Kivioja, A., Tyrmi, J., Toivonen, E., Huhtala, H., FinnGen, Jääskeläinen, T., Kettunen, J., Saarela, T., & Laivuori, H. (2025). Long‐term cardiovascular risk in women with hypertensive disorders of pregnancy: Insights from polygenic risk scores. Acta Obstetricia et Gynecologica Scandinavica. https://doi.org/10.1111/aogs.70021
Vancouver
Kivioja A, Tyrmi J, Toivonen E, Huhtala H, FinnGen, Jääskeläinen T, et al. Long‐term cardiovascular risk in women with hypertensive disorders of pregnancy: Insights from polygenic risk scores. Acta Obstetricia et Gynecologica Scandinavica. 2025. doi:10.1111/aogs.70021
BibTeX
@article{Kivioja2025,
author = {Kivioja, Anna and Tyrmi, Jaakko and Toivonen, Elli and Huhtala, Heini and FinnGen, FinnGen and Jääskeläinen, Tiina and Kettunen, Johannes and Saarela, Tanja and Laivuori, Hannele},
title = {Long‐term cardiovascular risk in women with hypertensive disorders of pregnancy: Insights from polygenic risk scores},
journal = {Acta Obstetricia et Gynecologica Scandinavica},
year = {2025},
doi = {10.1111/aogs.70021}
}
EUVIMED